Status:
WITHDRAWN
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Lead Sponsor:
Korea University
Conditions:
Type 2 Diabetes
Atherosclerosis
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus significantly increases the risk for the development of atherosclerosis. Recently, atherosclerosis imaging with 18F-FDG PET (18F-Fluorodeoxyglucose Positron Emission Tomograph...
Detailed Description
The early detection of vulnerable plaques is clinically important for risk stratification and also to provide early treatment. Inflammation is important in the both pathogenesis and outcome of atheros...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients who are aged 35 to 80 year-old
Exclusion
- Insulin use
- Patients who receive any dyslipidaemia under medications (including statins) in recent one year
- Women of child-bearing potential are excluded (i.e. menopausal women or post-hysterectomy women are included in this study) due to radiation exposure in this study
- Active inflammatory diseases
- Vasculitis, symptomatic coronary artery disease, symptomatic cerebrovascular diseases
- Significant concomitant disease such as active infection, malignancy, hepatic or renal dysfunction at the time of enrollment (i.e. T-Bil \> 3 mg/dl，ALT \> 2.5 times the upper limit of normal range and Creatinine \> 2 mg/dl in our hospital)
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00932048
Start Date
August 1 2011
End Date
March 1 2012
Last Update
September 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tae Nyun Kim
Seoul, South Korea, 152-050